Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2

Status

Unknown 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 479Lymphoid 4Sarcoma 1Genitourinary 1

Conditions

Lymphoma 2569Precursor Cell Lymphoblastic Leukemia-Lymphoma 2084Lymphoma, Non-Hodgkin 2055Leukemia, Lymphocytic, Chronic, B-Cell 1771Lymphoma, Follicular 1651Lymphoma, Large B-Cell, Diffuse 1596Leukemia 1170Hodgkin Disease 1127Lymphoma, Mantle-Cell 1110Burkitt Lymphoma 887Leukemia, Myeloid, Acute 884Lymphoma, B-Cell, Marginal Zone 788Recurrence 777Multiple Myeloma 744Lymphoma, B-Cell 702Myelodysplastic Syndromes 614Neoplasms 492Lymphoma, T-Cell, Cutaneous 479Waldenstrom Macroglobulinemia 470Lymphoma, Large-Cell, Immunoblastic 456Mycosis Fungoides 383Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Lymphoma, Large-Cell, Anaplastic 362Sezary Syndrome 321Lymphoma, T-Cell, Peripheral 320Leukemia, Myelogenous, Chronic, BCR-ABL Positive 307Hematologic Neoplasms 298Myeloproliferative Disorders 288Neoplasms, Plasma Cell 270Blast Crisis 261

Interventions

urelumab 1apatinib 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Advanced Solid Tumors × Lymphoid × Clear all
NCT06028373 2025-06-09

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Antengene Corporation

Phase 1 Recruiting
80 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT05564806 2023-09-07

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Eucure (Beijing) Biopharma Co., Ltd

Phase 1 Unknown
38 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT02253992 2020-10-05

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Bristol-Myers Squibb

Phase 1/2 Terminated
232 enrolled 17 charts
LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT02844881 2016-08-11

Study of Apatinib and MASCT in Patients With Advanced Solid Tumors

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
60 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡